+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

B

Actively Recruiting

Researchers are evaluating the effects of aglatimagene besadenovec combined with valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation therapy EBRT. This phase 2a, open-label, multi-center study aims to characterize viral shedding, biodistribution, and immune activation biomarkers to better understand the treatments impact. Approximately 45 participants will be enrolled, with 30 receiving the combination treatment and 15 receiving EBRT alone. Participants in the treatment group will receive three intraprostatic injections of aglatimagene besadenovec, each followed by a 14-day course of oral valacyclovir. EBRT will begin after the second injection. The control group will receive standard or moderately hypofractionated EBRT alone. Biospecimens including blood, urine, and semen will be collected at specific times before and after treatments to assess biodistribution and immune response. Throughout the study, participants will undergo continuous safety monitoring, including assessment of treatment-emergent adverse events and laboratory tests in the treatment group. Biomarkers related to immune activation and tumor burden will be analyzed up to five months after the last injection. The total study duration extends to approximately five months post-treatment, with ongoing evaluation of safety and biological effects.

Age: 18Years +MALEPhase 2
7 locations
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations